About Crpharm
Crpharm is a company based in Jinan (China) founded in 1938.. The company has 72,700 employees as of December 31, 2024. Crpharm has completed 1 acquisition, including Guizhou Tianan Pharmaceutical. Crpharm operates in a competitive market with competitors including Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Freeline, among others.
- Headquarter Jinan, China
- Employees 72700 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name China Resources Pharmaceutical Group Ltd.
-
Annual Revenue
$35.97 B (USD)3.32as on Dec 31, 2024
-
Net Profit
$467.39 M (USD)-14.7as on Dec 31, 2024
-
EBITDA
$2.07 B (USD)4.26as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
72700
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Crpharm
Crpharm is a publicly listed company on the HKEX with ticker symbol 3320 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Crpharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Crpharm
Crpharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Guizhou Tianan Pharmaceutical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic anti-diabetic drugs are manufactured in tablet and capsule forms.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Crpharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Crpharm Comparisons
Competitors of Crpharm
Crpharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Freeline, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for cardiovascular and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Crpharm
Frequently Asked Questions about Crpharm
When was Crpharm founded?
Crpharm was founded in 1938.
Where is Crpharm located?
Crpharm is headquartered in Jinan, China. It is registered at Jinan, Shandong, China.
How many employees does Crpharm have?
As of Dec 31, 2024, the latest employee count at Crpharm is 72,700.
What is the annual revenue of Crpharm?
Annual revenue of Crpharm is $35.97B as on Dec 31, 2024.
What does Crpharm do?
China Resources Sanjiu Medical Pharmaceutical Co. (flagship subsidiary of China Resources Group) is principally engaged in the research, development, manufacture, and distribution of pharmaceuticals. The Company is also involved in packaging printing, provision of medical healthcare services, as well as an international trading business. They have one of the most comprehensive pharmaceutical product portfolios among all Chinese Pharma Manufacturers, covering a range of therapeutic areas such as Chinese medicines and biopharmaceutical drugs, as well as nutritional and health products. They enjoy market-leading positions in nutritional Chinese medicines, cardiovascular system, alimentary tract and metabolism, large-volume IV infusion, anti-infection, reproductive health, cold and cough, dermatology, and Chinese medicine formula granules. They own a number of Well-Known Trademarks including Sanjiu (also known as 999), Double-Crane, Saike, Dong-E-E-Jiao, Zizhu, Yuting, Tianhe and Shenlu. The Companys pharmaceutical products include prescription drugs and over-the-counter (OTC) drugs. The Company distributes the products within domestic markets and overseas markets. In 2022, the company recorded annual revenues of 32.45B and a net profit of 0.53B.
Who are the top competitors of Crpharm?
Crpharm's top competitors include Tenaya Therapeutics, Cellino and Disc Medicine.
Is Crpharm publicly traded?
Yes, Crpharm is publicly traded on HKEX under the ticker symbol 3320.
How many acquisitions has Crpharm made?
Crpharm has made 1 acquisition, including Guizhou Tianan Pharmaceutical.
What is Crpharm's ticker symbol?
The ticker symbol of Crpharm is 3320 on HKEX.